title: [Should we assess the cost of a drug before prescribing it?].
authors.forename: M
authors.initials: M
authors.lastname: Giner Valero
authors.forename: M
authors.initials: M
authors.lastname: Feliu Sagalá
authors.forename: A
authors.initials: A
authors.lastname: López Martínez
authors.forename: L
authors.initials: L
authors.lastname: Gracia Romero
mesh_terms: D000897:Anti-Ulcer Agents / Q000191:economics; D000959:Antihypertensive Agents / Q000191:economics; D002121:Calcium Channel Blockers / Q000191:economics; D003365:Costs and Cost Analysis; D011307:Drug Prescriptions / Q000191:economics*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000191:economics*; D011320:Primary Health Care; D013030:Spain; D014665:Vasodilator Agents / Q000191:economics
chemical_list: D000897:Anti-Ulcer Agents; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004364:Pharmaceutical Preparations; D014665:Vasodilator Agents
vernacular_title: Debemos valorar el coste de un fármaco antes de prescribirlo?